P. Deloffre

1.5k total citations
22 papers, 1.2k citations indexed

About

P. Deloffre is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, P. Deloffre has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Orthopedics and Sports Medicine. Recurrent topics in P. Deloffre's work include Bone health and osteoporosis research (7 papers), Bone health and treatments (6 papers) and Cancer therapeutics and mechanisms (5 papers). P. Deloffre is often cited by papers focused on Bone health and osteoporosis research (7 papers), Bone health and treatments (6 papers) and Cancer therapeutics and mechanisms (5 papers). P. Deloffre collaborates with scholars based in France, Switzerland and Italy. P. Deloffre's co-authors include Y Tsouderos, Pierre J. Marie, M. Hott, Dominique Modrowski, Joël Guillemain, Cinderella de Pollak, Mathieu Mattèi, Christian Pradier, F. Tiger and G. Panczer and has published in prestigious journals such as Journal of Bone and Mineral Research, Intensive Care Medicine and Bone.

In The Last Decade

P. Deloffre

21 papers receiving 1.2k citations

Peers

P. Deloffre

OSM

ONCOL

SURGE

B. Krempien Germany

PD Delmas France

Sebert Jl France

Vincent J. Vigorita United States

C. Phenekos Greece

A. J. Darby United Kingdom

Jan Pødenphant Denmark

D. T. Baran United States

S. Pors-Nielsen Belgium

J Badurski France

B. Krempien Germany

P. Deloffre

350 ×0.7

OSM

456 ×1.2

ONCOL

355 ×1.0

405 ×1.4

SURGE

181 ×0.7

Citations per year, relative to P. Deloffre P. Deloffre (= 1×) peers B. Krempien

Countries citing papers authored by P. Deloffre

Since Specialization

Citations

This map shows the geographic impact of P. Deloffre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Deloffre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Deloffre more than expected).

Fields of papers citing papers by P. Deloffre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Deloffre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Deloffre. The network helps show where P. Deloffre may publish in the future.

Co-authorship network of co-authors of P. Deloffre

This figure shows the co-authorship network connecting the top 25 collaborators of P. Deloffre. A scholar is included among the top collaborators of P. Deloffre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Deloffre. P. Deloffre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marie, Pierre J., M. Hott, Dominique Modrowski, et al.. (2005). An Uncoupling Agent Containing Strontium Prevents Bone Loss by Depressing Bone Resorption and Maintaining Bone Formation in Estrogen-Deficient Rats. Journal of Bone and Mineral Research. 20(6). 1065–1074. 22 indexed citations

Hott, M., P. Deloffre, Y Tsouderos, & Pierre J. Marie. (2003). S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone. 33(1). 115–123. 109 indexed citations

Devissaguet, J.P., et al.. (1999). Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. European Journal of Drug Metabolism and Pharmacokinetics. 24(3). 265–271. 65 indexed citations

Bernardin, Gilles, Pilar de Lucas, Hervé Hyvernat, P. Deloffre, & Mathieu Mattèi. (1999). Influence of alveolar ventilation changes on calculated gastric intramucosal pH and gastric-arterial PCO2 difference. Intensive Care Medicine. 25(3). 269–273. 31 indexed citations

Henrotin, Yves, A Labasse, P. Deloffre, Y Tsouderos, & Jean‐Yves Reginster. (1998). Regulation of the chondrocyte metabolism by a new divalent strontium salt (S12911). Open Repository and Bibliography (University of Liège). 1 indexed citations

Grynpas, Marc D., Emma Hamilton, R. Cheung, et al.. (1996). Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone. 18(3). 253–259. 169 indexed citations

Boivin, Georges, P. Deloffre, G. Panczer, et al.. (1996). Strontium (Sr) distribution and interreactions with bone mineral in male monkey iliac bone after strontium salt (S12911) administration. Osteoporosis International. 6(S1). 251–251. 34 indexed citations

Ammann, Patrick, René Rizzoli, P. Deloffre, et al.. (1996). The increase in vertebral bone mass induced in intact rats by long-term administration of the strontium salt S-12911 is directly correlated with vertebral bone strength. Osteoporosis International. 6(S1). 259–259. 7 indexed citations

Boivin, Georges, P. Deloffre, G. Panczer, et al.. (1996). Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. Journal of Bone and Mineral Research. 11(9). 1302–1311. 217 indexed citations

10.

Deloffre, P., D. Hans, C. Rumelhart, et al.. (1995). Comparison between bone density and bone strength in glucocorticoid-treated aged ewes. Bone. 17(4). S409–S414. 17 indexed citations

11.

Marie, Pierre J., M. Hott, Dominique Modrowski, et al.. (1993). An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. Journal of Bone and Mineral Research. 8(5). 607–615. 307 indexed citations

12.

Milhaud, Didier, et al.. (1993). [Treatment of akinetic mutism with bromocriptine].. PubMed. 22(14). 688–688. 4 indexed citations

13.

Hott, M., Dominique Modrowski, P. Deloffre, Y Tsouderos, & Pierre J. Marie. (1992). S12911, A new agent containing strontium decreases bone resorption and increases trabecular bone mass in ovariectomized rats. Bone and Mineral. 17. 149–149. 1 indexed citations

14.

Su, Yanjun, J Bonnet, P. Deloffre, Y Tsouderos, & Ralf Baron. (1992). The strontium salt S12911 inhibits bone resorption in mouse calvaria and isolated rat osteoclasts cultures. Bone and Mineral. 17. 188–188. 14 indexed citations

15.

Arlot, M, P. Braillon, Jean‐Paul Roux, et al.. (1992). A new agent containing strontium (S 12911) has a protective effect on bone loss in ovariectomized rats. Bone. 13(5). A1–A1. 2 indexed citations

16.

Bartošek, I., et al.. (1991). Pharmacokinetic profile of fotemustine in rat plasma by electrochemical detection. Xenobiotica. 21(2). 235–242. 1 indexed citations

17.

Fischel, Jean–Louis, Patricia Formento, M C Etienne, et al.. (1990). In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea. Cancer Chemotherapy and Pharmacology. 25(5). 337–341. 25 indexed citations

18.

Tapiero, Haïm, et al.. (1990). Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.. PubMed. 9(6). 1617–22. 9 indexed citations

19.

Lokiec, François, et al.. (1989). [Study of the clinical pharmacokinetics of fotemustine in various tumor indications].. PubMed. 76(10). 1063–9. 6 indexed citations

20.

Deloffre, P., et al.. (1988). [Clinical pharmacokinetics of nitrosoureas].. PubMed. 75(8). 813–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact